enalaprilat (anhydrous)
CHEBI:CHEBI_4786
Definition
Enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor and is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is given by intravenous injection, usually as the dihydrate.
Chemical Information
- Molecular Formula
- C18H24N2O5
- Molecular Mass
- 348.39360
- Charge
- 0
- SMILES
- C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O
- InChI
- InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1
- InChIKey
- LZFZMUMEGBBDTC-QEJZJMRPSA-N
Alternative Names
- enalapril acid
- enalapril diacid
- enalaprilat
- Enalaprilat
- enalaprilat anhydrous
- enalaprilate
- enalaprilatum
- N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline
Treatment Applications
-
apolipoprotein A-IV associated amyloidosisView Disease →
DOID:0080927
-
focal segmental glomerulosclerosis 5View Disease →
DOID:0111130
-
lipoid nephrosisView Disease →
DOID:10966
-
membranous glomerulonephritisView Disease →
DOID:10976
-
diffuse glomerulonephritisView Disease →
DOID:4781
-
renal artery obstructionView Disease →
DOID:2972
-
Balkan nephropathyView Disease →
DOID:3052
-
exudative glomerulonephritisView Disease →
DOID:4777
-
subacute glomerulonephritisView Disease →
DOID:4782
Drug Classification
-
dipeptideView Class →
CHEBI:46761
-
dicarboxylic acidView Class →
CHEBI:35692
-
t227691
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- PDBeChem:EAL
- core#notation
- CHEBI:4786
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- PDBeChem:EAL
- oboInOwl#hasAlternativeId
- CHEBI:123355
- oboInOwl#id
- CHEBI:4786
- core#notation
- CHEBI:4786
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_35457
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_111117
- BFO_0000051
- http://purl.obolibrary.org/obo/CHEBI_59877
- chebi#has_functional_parent
- http://purl.obolibrary.org/obo/CHEBI_4784
- owl#annotatedSource
- t228328
- owl#someValuesFrom
- t255303